Jessica Sachs is Chief Medical Officer of Cogent Biosciences, Inc.. Currently has a direct ownership of 622 shares of COGT, which is worth approximately $4,876. The most recent transaction as insider was on Jun 30, 2022, when has been sold 622 shares (Common Stock) at a price of $7.39 per share, resulting in proceeds of $4,597. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 622
0% 3M change
0% 12M change
Total Value Held $4,876

Jessica Sachs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2022
BUY
Grant, award, or other acquisition
$4,597 $7.39 p/Share
622 Added 50.0%
622 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$4,597 $6.82 p/Share
674 Added 50.0%
674 Common Stock
JS

Jessica Sachs

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Track Activities on COGT